{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:33:22Z","timestamp":1790044402171,"version":"4.0.1"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PR9"],"published-print":{"date-parts":[[2017,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>A marked rise in opioid prescriptions for patients with chronic noncancer pain (CNCP) with a parallel increase in opioid abuse\/misuse, and resulting deaths was noted in the Unites states in the past decade (opioid epidemic). In response, the US Center of Diseases Control (CDC) developed a guideline for prescribing of opioids for patients with CNCP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To assess (1) if there is an opioid epidemic in Australia, Canada, and Germany (2) to compare Australian, Canadian, German, and Center of Diseases Control guidelines recommendations for long-term opioid therapy for CNCP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>National evidence-based guidelines and PubMed were searched for recommendations for opioid prescriptions for CNCP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>There are signs of an opioid epidemic in Australia and Canada, but not in Germany. Guidelines in all 4 countries provide similar recommendations: opioids are not the first-line therapy for patients with CNCP; regular clinical assessments of benefits and harms are necessary; excessive doses should be avoided (recommended morphine equivalent daily doses range from 50 to 200 mg\/d); stopping rules should be followed. All guidelines do not recommend the use of opioids in chronic pain conditions without an established nociceptive or neuropathic cause such as fibromyalgia and primary headache.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Implementation of opioid prescribing guidelines should ensure that physicians prescribe opioids only for appropriate indications in limited doses for selected patients and advice patients on their safe use. These measures could contribute to reduce prescription opioid misuse\/abuse and deaths.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/pr9.0000000000000599","type":"journal-article","created":{"date-parts":[[2017,5,13]],"date-time":"2017-05-13T10:06:22Z","timestamp":1494669982000},"page":"e599","source":"Crossref","is-referenced-by-count":127,"title":["The opioid epidemic and national guidelines for opioid therapy for chronic noncancer pain: a perspective from different continents"],"prefix":"10.1097","volume":"2","author":[{"given":"Winfried","family":"H\u00e4user","sequence":"first","affiliation":[{"name":"Department Internal Medicine 1, Klinikum Saarbr\u00fccken, Saarbr\u00fccken, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Schug","sequence":"additional","affiliation":[{"name":"Pharmacology, Pharmacy and Anaesthesiology Unit, School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia"},{"name":"Department of Anaesthesia and Pain Medicine, Royal Perth Hospital, Perth, WA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea D.","family":"Furlan","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Toronto, Institute for Work & Health, Toronto Rehab\u2014UHN, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230824","doi-asserted-by":"crossref","first-page":"c3800","DOI":"10.1136\/bmj.c3800","article-title":"The politics of pain","volume":"341","author":"Anderson","year":"2010","journal-title":"BMJ"},{"key":"R2-20230824","first-page":"A724","article-title":"UAW-News International Die unkritische Anwendung von Fentanylpflastern erh\u00f6ht das Risiko f\u00fcr schwerwiegende Nebenwirkungen (The uncritical use of fentanyl patches increases the risk of serious adverse events","volume":"109","year":"2012","journal-title":"Dtsch \u00c4rztebl"},{"key":"R3-20230824","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1056\/NEJMra025411","article-title":"Opioid therapy for chronic pain","volume":"349","author":"Ballantyne","year":"2003","journal-title":"N Engl J Med"},{"key":"R4-20230824","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/bcp.12446","article-title":"An overview of the patterns of prescription opioid use, costs and related harms in Australia","volume":"78","author":"Blanch","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"R5-20230824","first-page":"1","article-title":"Pain relief as a human right","volume":"12","author":"Brennan","year":"2004","journal-title":"Pain Clinical Updates"},{"key":"R6-20230824","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.jclinepi.2010.07.001","article-title":"On behalf of the AGREE Next Steps Consortium: AGREE II: Advancing guideline development, reporting and eval uation in healthcare","volume":"63","author":"Brouwers","year":"2010","journal-title":"J Clin Epidemol"},{"key":"R7-20230824","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1126\/science.aal2943","article-title":"Forecasting the opioid epidemic","volume":"35","author":"Burke","year":"2016","journal-title":"Science"},{"key":"R10-20230824","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpain.2008.10.008","article-title":"Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain","volume":"10","author":"Chou","year":"2009","journal-title":"J Pain"},{"key":"R11-20230824","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMsa1406143","article-title":"Trends in opioid analgesic abuse and mortality in the United States","volume":"372","author":"Dart","year":"2015","journal-title":"N Engl J Med"},{"key":"R12-20230824","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/pds.3931","article-title":"The extent and correlates of community-based pharmaceutical opioid utilisation in Australia","volume":"25","author":"Degenhardt","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R14-20230824","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1503\/cmaj.090784","article-title":"Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone","volume":"18","author":"Dhalla","year":"2009","journal-title":"CMAJ"},{"key":"R16-20230824","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-152-2-201001190-00006","article-title":"Opioid prescriptions for chronic pain and overdose: a cohort study","volume":"152","author":"Dunn","year":"2010","journal-title":"Ann Intern Med"},{"key":"R19-20230824","first-page":"97","article-title":"Opioids for chronic non-cancer pain: a critical view from the other side of the pond","volume":"82","author":"Fanelli","year":"2016","journal-title":"Minerva Anestesiol"},{"key":"R20-20230824","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol"},{"key":"R21-20230824","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/add.12224","article-title":"Non-medical use of prescription opioids and prescription opioid-related harms: why so markedly higher in North America compared to the rest of the world?","volume":"109","author":"Fischer","year":"2014","journal-title":"Addiction"},{"key":"R22-20230824"},{"key":"R24-20230824"},{"key":"R25-20230824","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5055\/jom.2012.0097","article-title":"The opioid manager: a point-of-care tool to facilitate the use of the Canadian Opioid Guideline","volume":"8","author":"Furlan","year":"2012","journal-title":"J Opioid Manag"},{"key":"R26-20230824","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1503\/cmaj.100187","article-title":"National Opioid Use Guideline Group. Opioids for chronic noncancer pain: a new Canadian practice guideline","volume":"182","author":"Furlan","year":"2010","journal-title":"CMAJ"},{"key":"R27-20230824","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/add.12598","article-title":"The burden of premature opioid-related mortality","volume":"109","author":"Gomes","year":"2014","journal-title":"Addiction"},{"key":"R28-20230824","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/archinternmed.2011.117","article-title":"Opioid dose and drug-related mortality in patients with nonmalignant pain","volume":"171","author":"Gomes","year":"2011","journal-title":"Arch Intern Med"},{"key":"R29-20230824","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ejpain.2007.10.012","article-title":"What do different databases tell about the use of opioids in seven European countries in 2002?","volume":"12","author":"Hamunen","year":"2008","journal-title":"Eur J Pain"},{"key":"R30-20230824","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s00482-014-1452-0","article-title":"Long-term opioid therapy in chronic noncancer pain. A systematic review and meta-analysis of efficacy, tolerability and safety in open-label extension trials with study duration of at least 26 weeks","volume":"29","author":"H\u00e4user","year":"2015","journal-title":"Schmerz"},{"key":"R31-20230824","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00482-014-1463-x","article-title":"Recommendations of the updated LONTS guidelines. Long-term opioid therapy for chronic noncancer pain","volume":"29","author":"H\u00e4user","year":"2015","journal-title":"Schmerz"},{"key":"R32-20230824","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2217\/pmt.16.5","article-title":"The opioid epidemic and the long-term opioid therapy for chronic noncancer pain revisited: a transatlantic perspective","volume":"6","author":"H\u00e4user","year":"2016","journal-title":"Pain Manag"},{"key":"R33-20230824","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.21596","article-title":"American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee","volume":"64","author":"Hochberg","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R35-20230824","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/bcp.12937","article-title":"Twenty-five years of prescription opioid use in Australia: a whole-of-population analysis using pharmaceutical claims","volume":"82","author":"Karanges","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"R36-20230824","first-page":"81","article-title":"Medication compliance in patients with chronic pain","volume":"17","author":"Kipping","year":"2014","journal-title":"Pain Physician"},{"key":"R38-20230824","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00482-005-0432-9","article-title":"Long-term efficiency of opioid medication in patients with chronic non-cancer-associated pain. Results of a survey 5 years after onset of medical treatment","volume":"19","author":"Maier","year":"2005","journal-title":"Schmerz"},{"key":"R39-20230824","doi-asserted-by":"crossref","first-page":"ES9","DOI":"10.36076\/ppj.2012\/15\/ES9","article-title":"Opioid epidemic in the United States","volume":"15","author":"Manchikanti","year":"2012","journal-title":"Pain Physician"},{"key":"R40-20230824","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/ejp.802","article-title":"Long-term opioid therapy for chronic non-cancer pain in Germany","volume":"20","author":"Marschall","year":"2016","journal-title":"Eur J Pain"},{"key":"R41-20230824","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.lpm.2016.02.014","article-title":"Use of strong opioids in chronic non-cancer pain in adults. Evidence-based recommendations from the French Society for the Study and Treatment of Pain","volume":"45","author":"Moisset","year":"2016","journal-title":"Presse Med"},{"key":"R42-20230824","first-page":"1","article-title":"Aktionsprogramm Schmerz","volume":"4","author":"M\u00fcller-Schwefe","year":"1998","journal-title":"Z Angew Schmerzth"},{"key":"R43-20230824","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jpain.2010.09.003","article-title":"A randomized trial of 2 prescription strategies for opioid treatment of chronic nonmalignant pain","volume":"12","author":"Naliboff","year":"2011","journal-title":"J Pain"},{"key":"R44-20230824","doi-asserted-by":"crossref","first-page":"696","DOI":"10.5694\/mja12.11331","article-title":"The sources of pharmaceuticals for problematic users of benzodiazepines and prescription opioids","volume":"199","author":"Nielsen","year":"2013","journal-title":"Med J Aust"},{"key":"R45-20230824","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12888-016-0909-3","article-title":"Nonmedical use of prescription drugs in the European Union","volume":"16","author":"Novak","year":"2016","journal-title":"BMC Psychiatry"},{"key":"R46-20230824","doi-asserted-by":"crossref","first-page":"38","DOI":"10.7326\/0003-4819-160-1-201401070-00732","article-title":"Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain","volume":"160","author":"Nuckols","year":"2014","journal-title":"Ann Intern Med"},{"key":"R47-20230824"},{"key":"R48-20230824","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMp1011512","article-title":"A flood of opioids, a rising tide of deaths","volume":"363","author":"Okie","year":"2010","journal-title":"N Engl J Med"},{"key":"R50-20230824"},{"key":"R51-20230824","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00482-014-1449-8","article-title":"Opioids in chronic low back pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration","volume":"29","author":"Petzke","year":"2015","journal-title":"Schmerz"},{"key":"R52-20230824","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/ip.2010.029611","article-title":"Increasing deaths involving oxycodone, Victoria, Australia, 2000-09","volume":"17","author":"Rintoul","year":"2011","journal-title":"Inj Prev"},{"key":"R53-20230824","doi-asserted-by":"crossref","first-page":"187","DOI":"10.5055\/jom.2014.0207","article-title":"An evaluation of the performance of the Opioid Manager clinical tool in primary care: a qualitative study","volume":"10","author":"Robertson","year":"2014","journal-title":"J Opioid Manag"},{"key":"R54-20230824","doi-asserted-by":"crossref","first-page":"280","DOI":"10.5694\/mja10.11450","article-title":"Prescription of opioid analgesics and related harms in Australia","volume":"195","author":"Roxburgh","year":"2011","journal-title":"Med J Aust"},{"key":"R55-20230824","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00482-014-1451-1","article-title":"Opioids in chronic osteoarthritis pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration","volume":"29","author":"Schaefert","year":"2015","journal-title":"Schmerz"},{"key":"R56-20230824","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s40264-014-0141-3","article-title":"Self-medication with over-the-counter and prescribed drugs causing adverse-drug-reaction-related hospital admissions: results of a prospective, long-term multi-centre study","volume":"37","author":"Schmiedl","year":"2014","journal-title":"Drug Saf"},{"key":"R57-20230824","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00228-002-0467-0","article-title":"Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study","volume":"58","author":"Schneeweiss","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"key":"R58-20230824","first-page":"45","article-title":"Increase in opiate prescription in Germany between 2000 and 2010: a study based on insurance data","volume":"110","author":"Schubert","year":"2013","journal-title":"Dtsch Arztebl Int"},{"key":"R59-20230824","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jclinepi.2008.10.009","article-title":"AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews","volume":"62","author":"Shea","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"R60-20230824","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1155\/2013\/651649","article-title":"Use and nonmedical use of prescription opioid analgesics in the general population of Canada and correlations with dispensing levels in 2009","volume":"18","author":"Shield","year":"2013","journal-title":"Pain Res Manag"},{"key":"R61-20230824","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00482-014-1455-x","article-title":"Opioids in chronic neuropathic pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration","volume":"29","author":"Sommer","year":"2015","journal-title":"Schmerz"},{"key":"R62-20230824","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1177\/0269216311398300","article-title":"Choosing the unit of measurement counts: the use of oral morphine equivalents in studies of opioid consumption is a useful addition to defined daily doses","volume":"25","author":"Svendsen","year":"2011","journal-title":"Palliat Med"},{"key":"R64-20230824","doi-asserted-by":"crossref","first-page":"E323","DOI":"10.36076\/ppj\/2015.18.E323","article-title":"Opioid therapy in the treatment of chronic pain conditions in Germany","volume":"18","author":"Werber","year":"2015","journal-title":"Pain Physician"}],"container-title":["PAIN Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01938936-201706000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T11:25:35Z","timestamp":1750245935000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01938936-201706000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/pr9.0000000000000599","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727883520.793535335","asserted-by":"object"}]},"ISSN":["2471-2531"],"issn-type":[{"value":"2471-2531","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5]]}}}